The SRE Motif in the Human PNPLA3 Promoter (−97 to −88 bp) Mediates Transactivational Effects of SREBP‐1c
- 5 February 2015
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 230 (9) , 2224-2232
Abstract
Patatin‐like phospholipase domain containing 3 (PNPLA3) is a non‐secreted protein primarily expressed in liver and adipose tissue. Recently, numerous genetic studies have shown that PNPLA3 is a major susceptibility gene for nonalcoholic fatty liver disease (NAFLD). However, the mechanism involved in transcriptional regulation of the PNPLA3 gene remains unknown. We performed a detailed analysis of the human PNPLA3 gene promoter and identified two novel cis‐acting elements (SRE and NFY binding motifs) located at −97/−88 and −26/−22 bp, respectively. Overexpression of SREBP‐1c in HepG2 cells significantly increased PNPLA3 promoter activity. Mutation of either of the putative SRE or NFY binding motifs blocked the transactivation effects of SREBP‐1c on the promoter. Overexpression of SREBP‐1c and NFY together increased PNPLA3 promoter activity twice as much as that of SREBP‐1c or NFY expression alone. This result suggests that SREBP‐1c and NFY synergistically transactivate the human PNPLA3 gene. The ability of SREBP‐1c and NFY to bind these cis‐elements was confirmed using gel shift analysis. Putative SRE and NFY motifs also mediated synergistic insulin‐induced transactivation of the PNPLA3 promoter in HepG2 cells. Additionally, the ability of SREBP‐1c to bind to the PNPLA3 promoter was increased by insulin in a dose‐dependent manner. Moreover, the treatment of HepG2 cells with the PI3K inhibitor LY294002 led to reduced insulin promoter‐activating ability accompanied by a decrease in PNPLA3 and SREBP‐1c protein expression. These results demonstrate that SREBP‐1c is a direct activator of the human PNPLA3 gene and insulin transactivates the PNPLA3 gene via the PI3K‐SREBP‐1c/NFY pathway in HepG2 cells. J. Cell. Physiol. 230: 2224–2232, 2015.Keywords
Funding Information
- ‘973’ Project (2012CB517506)
- National Natural Science Foundation of China (30900506, 81370909, 81000338)
- Guangdong Natural Science Foundation, China (S2012010008914, 10151008901000033)
- Fundamental Research Funds for the Central Universities (11ykpy36)
- Guangdong Department of Science & Technology Translational Medicine Center Grant (2011A080300002)
This publication has 33 references indexed in Scilit:
- High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in RatsPLOS ONE, 2013
- Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosisJournal of Clinical Investigation, 2012
- Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in JapanesePLOS ONE, 2012
- Adiponutrin Functions as a Nutritionally Regulated Lysophosphatidic Acid AcyltransferaseCell Metabolism, 2012
- A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver diseaseHuman Genetics, 2012
- Genetic Variant in PNPLA3 Is Associated With Nonalcoholic Fatty Liver Disease in ChinaHepatology, 2011
- A feed-forward loop amplifies nutritional regulation of PNPLA3Proceedings of the National Academy of Sciences, 2010
- A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severityJournal of Lipid Research, 2009
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Genome-Wide Occupancy of SREBP1 and Its Partners NFY and SP1 Reveals Novel Functional Roles and Combinatorial Regulation of Distinct Classes of GenesPLOS Genetics, 2008